Hetero Biopharma Limited, a active public limited company, was established on 14 September 2016 in Balanagar, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290TG2016PLC111946. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹166.00 Cr and a paid-up capital of ₹45.05 Cr.
It upholds a compliant status. Employing 486 professional, Its leadership includes Bandi Vamsikrishna (Director), Govindaraju Bhavani (Director), Parthasaradhi Reddy Bandi (Director). Past directors included Bhavesh Bansidhar Pujara, Bandi Vamsikrishna, Pankaj Jhawar. It holds ₹252.15 Cr open charges and no settled loans. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at #7-2-A2, Industrial Estate,, Sanath Nagar,, Balanagar, Telangana, 500018.
U24290TG2016PLC111946
111946
14 September 2016
₹166.00 Cr
₹45.05 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Hetero Biopharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bandi Vamsikrishna | Director | 25 Mar 2021 | Current |
| Govindaraju Bhavani | Director | 26 Aug 2022 | Current |
| Parthasaradhi Reddy Bandi | Director | 14 Sep 2016 | Current |
| Bhaskarreddy Pabbatireddy | Additional Director | 26 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 18 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Nov 2021 | Past |
| Pramod Abcsdd | Cfo(Kmp) | - | Past |
| Pramod Abcsdd | Additional Director | 14 Feb 2022 | Past |
| Pramod Abcsdd | Additional Director | 22 Sep 2022 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hetero Biopharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 13.44% increase. The company also saw a substantial fall in profitability, with a 33.65% decrease in profit. The company's net worth Soared by an impressive increase of 22.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Hetero Biopharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,521,493,423.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2025 | Sbicap Trustee Company Limited | ₹75.00 Cr | Open |
| 27 Mar 2025 | Sbicap Trustee Company Limited | ₹83.00 Cr | Open |
| 14 Feb 2024 | Others | ₹2.50 M | Open |
| 20 Feb 2023 | Others | ₹2.00 M | Open |
| 07 Jun 2022 | Others | ₹9.79 M | Open |
Explore comprehensive loan charge details -
Hetero Biopharma has a workforce of 486 employees as of Feb 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hetero Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetero Biopharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Bhaskarreddy Pabbatireddy was appointed as a Additional Director was appointed as a Additional Director on 26 Sep 2025 & has been associated with this company since 3 months 21 days . was documented.
The activity Hetero Biopharma Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was completed.
Progress on Hetero Biopharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
A charge with Sbicap Trustee Company Limited amounted to Rs. 75.00 Cr with Charge ID 101078891 was registered on 27 Mar 2025. was recorded as a recent event.
The activity A charge with Sbicap Trustee Company Limited amounted to Rs. 83.00 Cr with Charge ID 101077053 was registered on 27 Mar 2025. was completed.
A charge with Others of Rs. 92.72 Cr registered on 14 Sep 2021 with Charge ID 100482619 was modified on 17 Dec 2024. was recorded as a recent event.
The CIN of Hetero Biopharma Limited is U24290TG2016PLC111946.
Hetero Biopharma Limited is headquartered at #7-2-A2, Industrial Estate,, Sanath Nagar,, Balanagar, Telangana, 500018.
Hetero Biopharma Limited was incorporated on 14 September 2016.
The current directors of Hetero Biopharma Limited are
The primary industry of Hetero Biopharma Limited is Manufacturing.
Hetero Biopharma Limited is unlisted.
The authorized capital of Hetero Biopharma Limited is ₹166.00 Cr, and the paid-up capital is ₹45.05 Cr.
The compliance status of Hetero Biopharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX